We have analysts rating this as a buy with target prices ranging from $8 - $12. So, if don't have the big pop, which we all want, the future still will be promising. All this with FDA approval ofcourse.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.